Market Data on Cardiovascular and Diabetes

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
Databook
Databook

Company Financials: CSL Limited

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
20 Jan 2010 $75
Buy
Databook
Databook

Company Financials: Amylin Pharmaceuticals, Inc.

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
20 Jan 2010 $75
Buy
Databook
Databook

Company Financials: Altus Pharmaceuticals Inc.

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
20 Jan 2010 $75
Buy
Databook
Databook

Company Financials: Actelion Ltd

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
20 Jan 2010 $75
Buy
Interactive Model
Interactive Model

Commercial Insight: Cardiovascular and Metabolic Market Forecast

In-depth review of the cardiovascular and metabolic markets, including analysis and comparison of key sales trends in the therapy areas of diabetes, dyslipidemia, hypertension and thrombosis over the forecast (2010–19) period.

Published By Datamonitor
08 Feb 2011 $15200
Buy
Interactive Model
Interactive Model

Antidyslipidemics Market Forecast

Forecast of the antidyslipidemic markets in the US, Japan, France, Germany, Italy, Spain, and the UK. Volume and revenue sales forecast to 2019.

Published By Datamonitor
23 Aug 2010 $15200
Buy
Interactive Model
Interactive Model

Antidiabetics market forecast

Analysis of the competitive landscape and the recent changes in antidiabetics across seven major markets. Analysis of the threats to currently marketed drugs. Assessment of the opportunities available to novel agent classes.

Published By Datamonitor
17 Sep 2010 $15400
Buy
Interactive Model
Interactive Model

Antidiabetics in Australia Market Forecast

In-depth overview and ten year outlook for currently marketed and pipeline antidiabetic drugs in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Published By Datamonitor
20 Oct 2009 $5700
Buy

« | 1 | 2 | » »|

No help is available.